U.S. RESEARCH ROUNDUP- Blackstone, Coupang, Wells Fargo & Co

Lucid Diagnostics

15/04/2024 07:58

April 15 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Blackstone, Coupang and Wells Fargo & Co on
Monday. 
    
    HIGHLIGHTS
                 * Blackstone Inc  BX.N : JP Morgan raises target price to $105 from
 $96
 
                 * Coupang Inc  CPNG.N : Citigroup raises to buy from neutral
 
                 * Wells Fargo & Co  WFC.N : Piper Sandler raises target price to
 $61 from $56
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
    
                 * Antero Midstream Corp  AM.N : JP Morgan raises target price to $14 from $13
 
                 * Bank7 Corp  BSVN.O : Piper Sandler raises target price to $35 from $33
 
                 * BlackRock  BLK.N : JP Morgan cuts target price to $756 from $767
 
                 * Blackstone Inc  BX.N : JP Morgan raises target price to $105 from $96
 
                 * Citigroup  C.N : Piper Sandler raises target price to $70 from $67
 
                 * Coupang Inc  CPNG.N : Citigroup raises target price to $26 from $19
 
                 * Coupang Inc  CPNG.N : Citigroup raises to buy from neutral
 
                 * Daxor Corp  DXR.O : Ascendiant Capital Markets raises target price to $24.5
 from $24
 
                 * Dt Midstream Inc  DTM.N : JP Morgan raises target price to $64 from $62
 
                 * Enterprise Products Partners LP  EPD.N : JP Morgan raises target price to $33
 from $32
 
                 * Hershey Co  HSY.N : Piper Sandler cuts target price to $179 from $200
 
                 * JP Morgan  JPM.N : Piper Sandler cuts target price to $215 from $220
 
                 * Lucid Diagnostics Inc  LUCD.O : Ascendiant Capital Markets cuts PT to $8 from
 $8.5
 
                 * MSC Industrial Direct Co Inc  MSM.N : JP Morgan raises target price to $98
 from $95
 
                 * Neogen Corp  NEOG.O : Piper Sandler cuts target price to $17 from $19
 
                 * Novabay Pharmaceuticals Inc  NBY.A : Ascendiant Capital Markets cuts PT to $2
 from $3.5
 
                 * Pavmed Inc  PAVM.O : Ascendiant Capital Markets cuts target price to $26 from
 $30
 
                 * Virco Mfg Corp  VIRC.O : Wedbush raises target price to $16 from $14
 
                 * Wells Fargo & Co  WFC.N : Piper Sandler raises target price to $61 from $56
 
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))